Most importantly, what sort of securities did they offer against the loans.?? In the meantime, all I can see is that they are continuously making losses and where the Corporate costs are not decreasing either.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025